| Tacrolimus Hydrate is a disease-modifying antirheumatic drugs (DMARDs) Synonyms: Tsukubaenolide hydrate, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-hydrate, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-monohydrate CAS No: 109581-93-3 Free Base: 104987-11-3 Molecular Formula: C44H71NO13 Molecular Weight: 822.03 Purity: 98% Appearance: White to off-white solid Method of Determining Identity: 1H NMR Spectometric analysis Solubility: DMSO:~3mg/ml Storage and Stability: Store at -20C under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap. |
